Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1972 Aug;25(8):668–673. doi: 10.1136/jcp.25.8.668

Pulmonary fibrosis following therapy with Melphalan for multiple myeloma

B W Codling 1,2, T M H Chakera 1,2
PMCID: PMC477474  PMID: 5076801

Abstract

A patient suffering from multiple myeloma developed pulmonary fibrosis, of a type known to be associated wtih busulphan, whilst being treated with Melphalan.

The possible role of Melphalan as the causative agent is discussed. Reference is made to other possible aetiological agents and the reasons for their exclusion are discussed.

Full text

PDF
672

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. COCKERSOLE F. J., PARK W. W. Hexamethonium lung; report of a case associated with pregnancy. J Obstet Gynaecol Br Emp. 1956 Oct;63(5):728–734. doi: 10.1111/j.1471-0528.1956.tb05553.x. [DOI] [PubMed] [Google Scholar]
  2. Fleischman R. W., Baker J. R., Thompson G. R., Schaeppi U. H., Illievski V. R., Cooney D. A., Davis R. D. Bleomycin-induced interstitial pneumonia in dogs. Thorax. 1971 Nov;26(6):675–682. doi: 10.1136/thx.26.6.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. GABRIEL S. MULTIPLE MYELOMA PRESENTING AS PULMONARY INFILTRATION. REPORT OF A CASE. Dis Chest. 1965 Jan;47:123–126. doi: 10.1378/chest.47.1.123. [DOI] [PubMed] [Google Scholar]
  4. Hall R. M., Margolin F. R. Oxygen alveolopathy in adults. Clin Radiol. 1972 Jan;23(1):11–17. doi: 10.1016/s0009-9260(72)80129-6. [DOI] [PubMed] [Google Scholar]
  5. JENNNINGS F. L., ARDEN A. Development of radiation pneumonitis. Time and dose factors. Arch Pathol. 1962 Oct;74:351–360. [PubMed] [Google Scholar]
  6. Kirschner R. H., Esterly J. R. Pulmonary lesions associated with busulfan therapy of chronic myelogenous leukemia. Cancer. 1971 May;27(5):1074–1080. doi: 10.1002/1097-0142(197105)27:5<1074::aid-cncr2820270511>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  7. LEAKE E., SMITH W. G. DIFFUSE INTERSTITIAL PULMONARY FIBROSIS AFTER BUSULPHAN THERAPY. Lancet. 1963 Aug 31;2(7305):432–434. doi: 10.1016/s0140-6736(63)92173-1. [DOI] [PubMed] [Google Scholar]
  8. Littler W. A., Kay J. M., Hasleton P. S., Heath D. Busulphan lung. Thorax. 1969 Nov;24(6):639–655. doi: 10.1136/thx.24.6.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. OLINER H., SCHWARTZ R., RUBIO F., DAMESHEK W. Interstitial pulmonary fibrosis following busulfan therapy. Am J Med. 1961 Jul;31:134–139. doi: 10.1016/0002-9343(61)90229-7. [DOI] [PubMed] [Google Scholar]
  10. WALDENSTROEM J. MELPHALAN THERAPY IN MYELOMATOSIS. Br Med J. 1964 Apr 4;1(5387):859–865. doi: 10.1136/bmj.1.5387.859. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES